Literature DB >> 2885403

Association of an apolipoprotein CII allele with familial dementia of the Alzheimer type.

G D Schellenberg, S S Deeb, M Boehnke, E M Bryant, G M Martin, T H Lampe, T D Bird.   

Abstract

In order to identify the genetic locus responsible for familial dementia of the Alzheimer type (DAT), we are studying 10 families in which DAT appears to be inherited as an autosomal dominant trait. Genotypes for a TaqI restriction fragment length polymorphism (RFLP) at the apolipoprotein CII locus were determined for the following groups: affected and unaffected DAT family members, DAT subjects with no family history of the disease, and normal control subjects. The control group included 103 individuals from our study and 123 from the study of Wallis et al. (Hum. Genet., 68 (1984) 286). The frequency of the TaqI fast (F) allele in the affected familial DAT subjects (0.64 +/- 0.08) differed significantly from that for the control group (0.39 +/- 0.02) (Z = 2.87, P less than 0.005). In contrast, the F-allele frequency for the unaffected family members was 0.31 +/- 0.09, which was similar to that of the combined control group (Z = 0.78, P greater than 0.40). Subsequently, genotypes were determined for two other polymorphisms at the Apo CII locus: a BanI RFLP and a BglI RFLP. For these two polymorphisms, the allele frequencies for the familial DAT subjects differed from the unaffected control groups but the differences were smaller and not statistically significant. These data suggest a previously unrecognized association between the Apo CII TaqI F-allele and familial DAT.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2885403

Source DB:  PubMed          Journal:  J Neurogenet        ISSN: 0167-7063            Impact factor:   1.250


  20 in total

Review 1.  Genetic risk factors in Alzheimer's disease.

Authors:  L Tilley; K Morgan; N Kalsheker
Journal:  Mol Pathol       Date:  1998-12

Review 2.  Dyslipidemia and dementia: current epidemiology, genetic evidence, and mechanisms behind the associations.

Authors:  Christiane Reitz
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

3.  Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage.

Authors:  M A Pericak-Vance; J L Bebout; P C Gaskell; L H Yamaoka; W Y Hung; M J Alberts; A P Walker; R J Bartlett; C A Haynes; K A Welsh
Journal:  Am J Hum Genet       Date:  1991-06       Impact factor: 11.025

4.  Allele frequency estimation from data on relatives.

Authors:  M Boehnke
Journal:  Am J Hum Genet       Date:  1991-01       Impact factor: 11.025

5.  TOMM40 '523 Associations with Baseline and Longitudinal Cognition in APOE ɛ3 Homozygotes.

Authors:  Amber Watts; Heather M Wilkins; Elias Michaelis; Russell H Swerdlow
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

6.  Effects of Microglial Cytokines on Alzheimer's Disease-Related Phenomena.

Authors:  Yan Ji; Xiaowan Wang; Colin Kalicki; Blaise W Menta; Megan Baumgardner; Scott J Koppel; Ian W Weidling; Judit Perez-Ortiz; Heather M Wilkins; Russell H Swerdlow
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 7.  DNA polymorphism and the study of disease associations.

Authors:  D N Cooper; J F Clayton
Journal:  Hum Genet       Date:  1988-04       Impact factor: 4.132

Review 8.  Genomic variants, genes, and pathways of Alzheimer's disease: An overview.

Authors:  Adam C Naj; Gerard D Schellenberg
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-01       Impact factor: 3.568

9.  Estimating the probability for major gene Alzheimer disease.

Authors:  L A Farrer; L A Cupples
Journal:  Am J Hum Genet       Date:  1994-02       Impact factor: 11.025

10.  Chromosome 14 and late-onset familial Alzheimer disease (FAD).

Authors:  G D Schellenberg; H Payami; E M Wijsman; H T Orr; K A Goddard; L Anderson; E Nemens; J A White; M E Alonso; M J Ball
Journal:  Am J Hum Genet       Date:  1993-09       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.